Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2001

View Archived Issues

New series of chemokine receptor-binding compounds and uses reported by AnorMED

Modulators of dopamine neurotransmission presented in recent patents

ADIR patents novel treatments for endothelial dysfunction

Three related series of PDE4 inhibitors in development at Icos

Endothelin receptor antagonists identified by Actelion team

Liver-specific MRI contrast agent launched in Sweden

Modified second-generation taxoids: design and SAR discussed at ACS

Pfizer presents new sulfonamide-based compounds with high selectivity for MMP-3

Simplified salicylihalimide analogues which retain antitumor activity

BTG obtains rights to ANF peptide technology from Genentech

Antidiabetic effects of GW-0072, a new SPARM, examined in animal model of type 2 diabetes

Zeria licenses rights to Visicol from InKine

Glucose excursion decreased, formation of new beta-cells enhanced by DPP IV inhibitor

Jomed and Oxigene form collaboration on restenosis inhibitors

Positive results obtained in phase II Chronogesic trial for long-term pain relief

Orally active NO-independent sGC stimulators from Bayer with vasodilating and hypotensive activity

HGS initiates new clinical trial with repifermin for treatment of mucositis

Janssen seeks FDA approval of new long-acting Risperdal formulation

Ortec's OrCel approved for healing donor site wounds in burn victims

Phase I trials commence for another peripheral kappa opioid receptor agonist from Adolor

Epicyte and Dow collaborate with Centocor on production of therapeutic MAbs in plants

New HCV target discovered at Myriad Genetics, drug development program initiated

WHI-P131: a dual-acting antileukemic, anti-GVHD compound targeting JAK3

Cellegy seeks MCA approval of Rectogesic for treatment of anal fissures

Data from first study in female Fabry's disease patients discussed at recent workshop

Maxygen and InterMune to develop next-generation interferon gamma products

Pivotal trials of daptomycin advance in anticipation of 2003 launch

Gene transfer of COX-1 proves to restore PGI2 synthesis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.